Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

被引：2
|
作者：
Napolitano, Mariasanta [1 ]
Siragusa, Sergio [1 ]
机构：
[1] Univ Palermo, UOC Ematol Con Trapianto, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy
来源：
THROMBOSIS RESEARCH | 2017年 / 158卷
关键词：
Low molecular weight heparin; Tinzaparin; Cancer associated thrombosis; Recurrences; Bleeding; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; VEIN THROMBOSIS; TRIAL;
D O I：
10.1016/j.thromres.2017.09.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [41] Tailoring treatment for MALT lymphoma patients: where do we stand now?
    Johnson, Peter W.
    Thieblemont, Catherine
    Zucca, Emanuele
    ONCOTARGET, 2017, 8 (70) : 114422 - 114423
  • [42] ADVANCED OVARIAN-CANCER - WHERE DO WE STAND AND WHERE DO WE GO - PREFACE
    LUND, B
    NEIJT, J
    ANNALS OF ONCOLOGY, 1993, 4 : 1 - 1
  • [43] Colon Cancer Prevention 4.0 Where do we stand, where do we want to go?
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (04): : 375 - 376
  • [44] Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand?
    Barbetta, Arianna
    Faraz, Shahdabul
    Shah, Pari
    Gerdes, Hans
    Hsu, Meier
    Tan, Kay See
    Nobel, Tamar
    Bains, Manjit S.
    Bott, Matthew
    Isbell, James M.
    Sewell, David B.
    Jones, David R.
    Molena, Daniela
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (05) : 778 - 784
  • [45] Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand?
    Arianna Barbetta
    Shahdabul Faraz
    Pari Shah
    Hans Gerdes
    Meier Hsu
    Kay See Tan
    Tamar Nobel
    Manjit S. Bains
    Matthew Bott
    James M. Isbell
    David B. Sewell
    David R. Jones
    Daniela Molena
    Journal of Gastrointestinal Surgery, 2018, 22 : 778 - 784
  • [46] Gephyrin: where do we stand, where do we go?
    Fritschy, Jean-Marc
    Harvey, Robert J.
    Schwarz, Guenter
    TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 257 - 264
  • [47] Squamous Cell Lung Cancer: Where Do We Stand and Where Are We Going?
    Hirsch, Fred R.
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 914 - 915
  • [48] Immunization in cancer patients: Where we stand
    Robin, Christine
    Beckerich, Florence
    Cordonnier, Catherine
    PHARMACOLOGICAL RESEARCH, 2015, 92 : 23 - 30
  • [49] Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?
    Mahipal, Amit
    Choi, Minsig
    Kim, Richard
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (10): : 1281 - 1292
  • [50] PI3K inhibitors for cancer treatment: where do we stand?
    Maira, Sauveur-Michel
    Stauffer, Frederic
    Schnell, Christian
    Garcia-Echeverria, Carlos
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 : 265 - 272
12345